Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

MSE PRO (R)-2-(2,5-Difluorophenyl)pyrrolidine, ≥97.0% Purity– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

MSE PRO (R)-2-(2,5-Difluorophenyl)pyrrolidine, ≥97.0% Purity - MSE Supplies LLC

MSE PRO (R)-2-(2,5-Difluorophenyl)pyrrolidine, ≥97.0% Purity

SKU: CM1378

  • $ 29995


MSE PRO™ (R)-2-(2,5-Difluorophenyl)pyrrolidine, ≥97.0% Purity

MSE PRO™ (R)-2-(2,5-Difluorophenyl)pyrrolidine is a chiral pyrrolidine derivative containing two fluorine atoms on the phenyl ring and exists as the (R)-enantiomer. The presence of the fluorinated phenyl ring and the rigid pyrrolidine ring system make this compound a versatile synthetic intermediate for the preparation of various nitrogen-containing heterocyclic compounds and pharmaceutically active molecules. As a chiral building block, it can be employed in enantioselective synthesis, enabling the construction of optically pure drugs, agrochemicals, and other biologically active compounds where stereochemical purity is crucial for potency and selectivity.

For Research Use Only (RUO). Not for use in diagnostic procedures. 

 MSE Supplies offers various N-heterocyclic drug small molecules and other chemical reagents. Please contact us for bulk orders.

Technical Specifications:

CAS No. 1218935-59-1
Chemical name (R)-2-(2,5-Difluorophenyl)pyrrolidine
Synonym(s)
  • (2R)-2-(2,5-difluorophenyl)pyrrolidine
Molecular formula C10H11F2N      
Pack size

1 g (CM1378)

Molecular weight 183.20 g/mol
Purity ≥97.0% (NMR)
Boiling point    213.5±40.0 °C (Predicted) 
Density  1.164±0.06 g/mL (Predicted)
pKa 9.02±0.10 (Predicted)
Appearance Light yellow to yellow liquid
Storage 
2-8°C, protect from light


References:

[1] Cox, C. D., Coleman, P. J., Breslin, M. J., Whitman, D. B., Garbaccio, R. M., Fraley, M. E., ... & Hartman, G. D. (2008). Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2 S)-4-(2, 5-Difluorophenyl)-N-[(3 R, 4 S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2, 5-dihydro-1 H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer. Journal of medicinal chemistry51(14), 4239-4252.

[2] Chen, Q., Li, B. B., Zhang, L., Chen, X. R., Zhu, X. X., Chen, F. F., ... & Zheng, G. W. (2022). Engineered imine reductase for Larotrectinib intermediate manufacture. ACS Catalysis12(23), 14795-14803.